Evidence map›Paper›PMID 41989039›Full record

ArticleThe Journal of organic chemistry2026

Trials into Triumphs: The Emergence of a Concise Total Synthesis of Hinckdentine A.

Daler Baidilov, Pavel K Elkin, Viresh H Rawal

Abstract read
In one paragraph

Article in The Journal of organic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daler BaidilovDepartment of Chemistry, University of Chicago, Chicago, Illinois 60637, United States.
Pavel K ElkinDepartment of Chemistry, University of Chicago, Chicago, Illinois 60637, United States.ORCID 0000-0002-3446-4589
Viresh H RawalDepartment of Chemistry, University of Chicago, Chicago, Illinois 60637, United States.ORCID 0000-0003-4606-0239

Funding

New Methods and Strategies for the Concise Synthesis of Complex Indole AlkaloidsR01GM144663 · NIGMS · UNIVERSITY OF CHICAGO · PI RAWAL, VIRESH H. · 2021 to 2024
$1.3M
Methods and Strategies for Concise Syntheses of Intricate Bioactive CompoundsR35GM158168 · NIGMS · UNIVERSITY OF CHICAGO · PI VIRESH H. RAWAL · 2025 to 2026
$850k
NIGMS NIH HHS R01 GM144663NIGMS NIH HHS R35 GM158168
6 · The paper itself

Abstract

Nonintuitive retrosynthetic disconnections can offer valuable insights for devising efficient synthetic routes to complex natural products. When such disconnections involve skeletal rearrangements, they often allow advanced intermediates to be traced back to much simpler building blocks. Guided by this paradigm and motivated by the aspiration to achieve the "ideal synthesis", we have undertaken multiple generations of development to accomplish a concise synthesis of the unique, propeller-shaped natural product hinckdentine A. At the core of our strategy is a novel dearomative indolic-Claisen rearrangement that efficiently transfers the chirality of a readily introduced alcohol to a newly formed, fully substituted chiral center. The resulting densely substituted tertiary amide intermediate was pivotal for progressing toward the final target. The route, however, was far from straightforward, and several pathways were explored, and numerous challenges were overcome before successfully advancing this intermediate to hinckdentine A. This comprehensive account details the evolution of our synthetic campaign, highlighting the unforeseen obstacles encountered and strategic maneuvers devised to surmount them en route to a concise synthesis of the natural product.

Indexed as

Biological ProductsMolecular StructureStereoisomerismBiological Products

Identifiers

PMID41989039
PMCPMC13626292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.